# FDA 483 - Hill Dermaceuticals, Inc. - October 14, 2025

Source: https://www.keypedia.com/records/483/hill-dermaceuticals-inc/a50aef9d-f4a0-4b75-98bb-3747db7aab0a

> FDA 483 for Hill Dermaceuticals, Inc. on October 14, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Hill Dermaceuticals, Inc.
- Inspection Date: 2025-10-14
- Product Type: drugs
- Office Name: Florida District Office
- Summary: Hill Dermaceuticals, Inc. in Sanford, FL, was inspected and cited for significant deficiencies across its manufacturing operations and supply chain security. Observations included poorly maintained equipment and facilities posing contamination risks, inadequate calibration controls for critical instruments, and a complete lack of systems to comply with Drug Supply Chain Security Act verification requirements. These issues indicate a serious lapse in maintaining a state of control over drug product quality and traceability.

## Related Documents

- [483 - 2021-08-11](https://www.keypedia.com/records/483/hill-dermaceuticals-inc/03ee59a5-26b6-4687-8270-ec345acd064b)

## Related Officers

- [Mabany Lizardi](https://www.keypedia.com/people/mabany-lizardi/adcca71c-e996-44e5-9827-d1aa2773e832)
- [Michael Z. Weigman](https://www.keypedia.com/people/michael-z-weigman/fcf79bb1-87cc-476c-a1af-758ef0126ee9)

Company: https://www.keypedia.com/companies/hill-dermaceuticals-inc/f3bca28c-18cf-4743-8a40-705b02d4cc9c

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9